Table 1.

CONS of rechallenging with immune checkpoint inhibitors

1	Recurrence of AKI
2	Potential RRT dependency
3	Increased hospitalizations
4	Accelerated progression to severe CKD
5	Increased health care utilization
6	Risk of irAE in other organs

irAE, immune-related adverse effects; RRT, renal replacement therapy.